Slightly tangential to New vendor application but alex_tucson reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

I know this thread is old but I found it through search and wanted to add my experience with New vendor application since this was the most comprehensive discussion I could find.

11 months later, the information in this thread still holds up. My results have been even better than expected based on this discussion.

For anyone else finding this through search: the advice here is solid. Some of the vendor information may be outdated.

Want to share my personal experience related to New vendor application April since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 245 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 16 months later: I am down 50 lbs, my labs have normalized, and I am off 2 of my 3 medications. The New vendor applicati aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

Relevant to New vendor application April — here is my latest bloodwork comparison:

Key improvements: A1C 7.6% → 5.5%, triglycerides 221 → 91 mg/dL, hsCRP 8.0 → 0.9 mg/L. All on tirzepatide for 13 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

I know this thread is old but I found it through search and wanted to add my experience with New vendor application since this was the most comprehensive discussion I could find.

8 months later, the information in this thread still holds up. My results have been consistent with the data shared here.

For anyone else finding this through search: the advice here is solid. The clinical trial landscape has evolved since then.